Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Newstrike Brands Ltd NWKRF

"Newstrike Brands Ltd is a licensed producer and cultivator of medical cannabis based in Brantford, Ontario. The company cultivates and sells both forms including dried and fresh marihuana."

OTCPK:NWKRF - Post Discussion

Newstrike Brands Ltd > CMED not getting HIP
View:
Post by IMB51479 on Jan 12, 2018 3:08pm

CMED not getting HIP

CMED is dragging down this stock with thier low ball offer. CMED shareholders will never approve the HIP transaction. They want ACB to take over. 
Once ACB and CMED are one HIP will recover and/or find anotrher suitor. HIP doesn't need CMED
Comment by stckapprentice on Jan 12, 2018 3:12pm
agreed, but it seems like the deal will go through from what is in the news... though of course anything would happen. they could offer hip shareholders more to put the deal through and it could work out.. but if stays the same... wow I guess I'll be holding cmed until they hit 90-100 $ then I might be old and gray
Comment by HansonLockyer on Jan 12, 2018 3:52pm
This post has been removed in accordance with Community Policy
Comment by SecondLast on Jan 12, 2018 3:21pm
Im not so sure they wont. HIP management was on BNN the yesterday saying they still support the transsaction and that a few days of wild trading wouldnt change their opinion and the HIP came out this morning and said they support the CMED offer. HIP doesnt grow enough for the 1.5BN market cap it hit a couple days back.
Comment by Drocker on Jan 12, 2018 3:25pm
Thats why it won't go at a premium to $3.30 but a premium to CURRENT market value. If that value is 1.50 or 5.00 doesn't matter it must and always will be for all buy outs a premium to that price!
Comment by Whitewitch on Jan 12, 2018 3:22pm
This post has been removed in accordance with Community Policy
Comment by stckapprentice on Jan 12, 2018 3:26pm
I guess we heard yes Hip has been approved to sell.  boom stock shoots up. we join hoping for  forward momentum and gains... instead insiders move to sell and short and then rebuy. locking in huge gains. Meanwhile... the rest of us are out big money . some more than others. I mean this is the name of the game...but damn talk about kick backs and holding a value from last year without ...more  
Comment by dionsays on Jan 12, 2018 3:32pm
If the deal happened last year both HIP and Cmed would have climbed. Unfortunately ACB through insider info got involved and it stalled everything. Has anyone heard of the outcome as of yet: How did ACB know that cmed was buying out Hip?
Comment by SecondLast on Jan 12, 2018 3:29pm
HIP is planning for 25000kg/yr production in 2019. Im guessing you bought at a $1.3+BN market cap MARI has 22500kg/yr probably ready for legalization, 95000 by late 2019 at 300MN market cap TRST has 23000 for legalization, 43000 by 2019 at 550MN THCX has 3600 for legalization, 108000 by 2019 at 500MN Market cap. I think HIP is overvalued right now comparitavely, because of the tragically ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities